other material
confidence high
sentiment positive
materiality 0.75
Lunai Bioworks lands first defense contract, sues naked short sellers over 81.6% FTD shares
Lunai Bioworks Inc.
- Secured first revenue-generating multi-year defense collaboration via BioSymetrics for chemical threat assessment.
- Formed Pathfinder Consortium with Harvard, Brigham & Women's, Purdue, Utah, Colorado for biodefense.
- Partnered with BrainStorm Therapeutics; awarded $1.85M NIH STTR grant for alcohol use disorder.
- Filed May 2026 lawsuit against unidentified parties; 29.6M fails-to-deliver (81.6% of shares); court granted expedited discovery.
- Achieved compliance with Nasdaq listing requirements.